Literature DB >> 20127135

Association analysis of CD40 gene polymorphism with acute coronary syndrome.

Jinchuan Yan1, Cuiping Wang, Rongzeng Du, Peijin Liu, Guanghua Chen.   

Abstract

Current evidence shows that the CD40-CD40 ligand (CD40-CD40L) system plays a crucial role in the development, progression and outcome of acute coronary syndrome (ACS). The aim of this study is to investigate whether a CD40 gene (-1C/T) single nucleotide polymorphism (SNP) is associated with ACS and CD40 expression. We included controls (n = 163) and patients with either ACS (n = 210) or stable angina (SA, n = 189) in the study. The gene polymorphism was measured using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and identified by sequencing. CD40 expression on platelets was detected by flow cytometry. The results showed that the frequency of the CC genotype of CD40 gene in the ACS group was significantly higher than in the SA and control groups (P < 0.001), while the TT genotype frequency in the ACS group was significantly lower than that of the SA and control groups (P < 0.001). The C-allele frequency of the ACS group was higher than that of the SA and control groups (P < 0.001). The C allele increased the risk of ACS when compared with the SA group (OR = 1.841, 95% CI: 1.390-2.437) and the control groups (OR = 1.877, 95% CI: 1.402-2.515). No significant differences in genotypes or allele frequencies were found between the SA and control groups. CD40 expression on platelets in patients with C-allele carriers was significant higher than in the T-allele carriers in each group. In conclusion, our results suggested that the CD40 gene (-1C/T) polymorphism was associated with ACS in Chinese people. The -1C-allele gene carriers had a higher expression of CD40 and an increased risk of suffering from ACS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127135     DOI: 10.1007/s10238-010-0092-7

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  22 in total

Review 1.  Platelets in inflammation and atherogenesis.

Authors:  Meinrad Gawaz; Harald Langer; Andreas E May
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.

Authors:  E M Jacobson; A K Huber; N Akeno; M Sivak; C W Li; E Concepcion; K Ho; Y Tomer
Journal:  Genes Immun       Date:  2007-03-08       Impact factor: 2.676

3.  Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

Authors:  P Aukrust; F Müller; T Ueland; T Berget; E Aaser; A Brunsvig; N O Solum; K Forfang; S S Frøland; L Gullestad
Journal:  Circulation       Date:  1999-08-10       Impact factor: 29.690

4.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094

5.  A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese.

Authors:  Tokunori Mukai; Yuji Hiromatsu; Tomoka Fukutani; Michiko Ichimura; Hiroo Kaku; Ikuyo Miyake; Kentaro Yamada
Journal:  Endocr J       Date:  2005-08       Impact factor: 2.349

6.  A functional TNFRSF5 gene variant is associated with risk of lymphoma.

Authors:  Christine F Skibola; Alexandra Nieters; Paige M Bracci; John D Curry; Luz Agana; Danica R Skibola; Alan Hubbard; Nikolaus Becker; Martyn T Smith; Elizabeth A Holly
Journal:  Blood       Date:  2008-02-20       Impact factor: 22.113

7.  Effect of CD40--CD40 ligand interaction on diacylglycerol-protein kinase C and inositol trisphosphate-Ca(2+) signal transduction pathway in human umbilical vein endothelial cells.

Authors:  Jin-Chuan Yan; Zong-Gui Wu; Xian-Tao Kong; Ren-Qian Zong; Lin-Zen Zhan
Journal:  Clin Chim Acta       Date:  2003-11       Impact factor: 3.786

8.  A C >T polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women.

Authors:  B Pineda; P Laporta; C Hermenegildo; A Cano; M A García-Pérez
Journal:  Osteoporos Int       Date:  2007-12-21       Impact factor: 4.507

9.  Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.

Authors:  Jin-chuan Yan; Zong-gui Wu; Xian-tao Kong; Ren-qian Zong; Lin-zen Zhan
Journal:  Acta Pharmacol Sin       Date:  2004-02       Impact factor: 6.150

Review 10.  The CD40/CD40 ligand system: linking inflammation with atherothrombosis.

Authors:  Charalambos Antoniades; Constantinos Bakogiannis; Dimitris Tousoulis; Alexios S Antonopoulos; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

View more
  7 in total

1.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

2.  Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population.

Authors:  Jiao Lou; Rong Zhong; Na Shen; Xu-zai Lu; Jun-tao Ke; Jia-yu Duan; Yan-qi Qi; Yu-jia Wang; Qing Zhang; Wei Wang; Fang-qi Gong; Xiao-ping Miao
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

3.  The association of IL-17A polymorphisms with IL-17A serum levels and risk of ischemic stroke.

Authors:  Hua-Tuo Huang; Yu-Lan Lu; Rong Wang; Hai-Mei Qin; Chun-Fang Wang; Jun-Li Wang; Yang Xiang; Jing Guo; Yan Lan; Ye-Sheng Wei
Journal:  Oncotarget       Date:  2017-10-05

4.  A SNP in 5' untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study.

Authors:  Hua-Tuo Huang; Jing Guo; Yang Xiang; Jian-Ming Chen; Hong-Cheng Luo; Lan-Qing Meng; Ye-Sheng Wei
Journal:  Genet Mol Biol       Date:  2017-06-05       Impact factor: 1.771

5.  The SNP rs1883832 in CD40 gene and risk of atherosclerosis in Chinese population: a meta-analysis.

Authors:  Yan Yun; Chi Ma; XiaoChun Ma
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 6.  CD40 in coronary artery disease: a matter of macrophages?

Authors:  Matthijs F Jansen; Maurits R Hollander; Niels van Royen; Anton J Horrevoets; Esther Lutgens
Journal:  Basic Res Cardiol       Date:  2016-05-04       Impact factor: 17.165

7.  Association Study between an SNP in CD147 and Its Expression With Acute Coronary Syndrome in a Jiangsu Chinese Population.

Authors:  Jinchuan Yan; Yu Mao; Cuiping Wang; Zhongqun Wang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.